Skip to content
GenoLensGenoLens

PTPN1

Chr 20q13.13

protein tyrosine phosphatase non-receptor type 1

MANE:
ENST00000371621.5

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Autoinflammatory disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Childhood onset dystonia, chorea or related movement disorder

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Childhood onset hereditary spastic paraplegia

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • White matter disorders and cerebral calcification - narrow panel

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • neurodegenerative disease

    0.53
  • Alzheimer disease

    0.47
  • Parkinson disease

    0.47
  • multiple sclerosis

    0.46
  • lysosomal storage disease

    0.46
  • hypothyroidism

    0.40
  • mathematical ability

    0.38
  • colorectal cancer

    0.31
  • tooth disorder

    0.31
  • type 1 diabetes mellitus

    0.30

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Tyrosine-protein phosphatase non-receptor type 1

Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of MET

Curated MONDO disease pages that list PTPN1 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.